BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31627963)

  • 1. Review of the experience and evidence of Pygeum africanum in urological practice.
    Salinas-Casado J; Esteban-Fuertes M; Carballido-Rodríguez J; Cozar-Olmo JM
    Actas Urol Esp (Engl Ed); 2020; 44(1):9-13. PubMed ID: 31627963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)].
    Cambronero J; Osca-García JM; Merino-Salas S; Miguel JM; Borralleras C; López-Alcina E
    Arch Esp Urol; 2022 Apr; 75(3):219-227. PubMed ID: 35435166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
    Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
    Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS.
    Edgar AD; Levin R; Constantinou CE; Denis L
    Neurourol Urodyn; 2007; 26(4):458-463. PubMed ID: 17397059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complimentary therapy for male LUTS.
    Cheetham PJ
    Curr Urol Rep; 2013 Dec; 14(6):606-13. PubMed ID: 24026362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
    Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
    Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence.
    Carrero-López VM; Cózar-Olmo JM; Miñana-López B
    Actas Urol Esp; 2016 Jun; 40(5):288-94. PubMed ID: 26823069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
    Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
    Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
    Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H
    Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Dedhia RC; McVary KT
    J Urol; 2008 Jun; 179(6):2119-25. PubMed ID: 18423748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytotherapy for male luts: What happens then? 10-year research.
    Luciani LG; Mattevi D; Vattovani V; Cai T; Giusti G; Malossini G
    Actas Urol Esp (Engl Ed); 2022 Sep; 46(7):442-446. PubMed ID: 35337768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we really need herbal medicine in LUTS/BPH treatment in the 21
    Pinggera GM; Frauscher F
    Expert Opin Drug Saf; 2016 Dec; 15(12):1573-1575. PubMed ID: 27461908
    [No Abstract]   [Full Text] [Related]  

  • 16. Botanical derivatives for the prostate.
    Cristoni A; Di Pierro F; Bombardelli E
    Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.
    Larré S; Camparo P; Comperat E; Boulbés D; Haddoum M; Baulande S; Soularue P; Costa P; Cussenot O
    Asian J Androl; 2012 May; 14(3):499-504. PubMed ID: 22198631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.